Claris Lifesciences gains more than 8% intraday on buyback approval

Written by fe Bureau | Mumbai | Updated: Mar 22 2014, 01:07am hrs
Shares of Claris Lifesciences gained more than 8% intraday after the drugmaker said that the equity shareholders of the company had approved the Rs 231 crore buyback.

"The equity shareholders of the company have approved the buy back of up to 92.50 lakh shares," the company said in an exchange filing on Friday. The buyback has been priced at Rs 250.

The scrip ended 0.69% higher at Rs 181.60 on Friday on the BSE.